AbbVie acquires Botox-maker Allergan in ‘turning point’ deal

By Lucy Tandon Copp 15-May-2020

The acquisition will see AbbVie achieve approximately US$30bn in full-year 2020 revenues

AbbVie, the biopharmaceutical company, has acquired Allergan in what its CEO described as an “important milestone”.

Sign up for your free email newsletter

The acquisition includes Allergan’s global aesthetics...

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Subscribe now to premium content on Cosmetics Business


Subscriber Help